查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1842020

美國主動脈瓣置換裝置市場：市場規模、佔有率、趨勢分析（按產品、瓣葉材料、支架材料和最終用途分類）、細分市場預測（2025-2033 年）

U.S. Aortic Valve Replacement Devices Market Size, Share & Trends Analysis Report By Product, By Leaflet Material, By Frame Material, By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

美國主動脈瓣置換裝置市場摘要

2024 年美國主動脈瓣置換裝置市場規模估計為 40.8 億美元，預計到 2033 年將達到 93.5 億美元，2025 年至 2033 年的複合年成長率為 9.4%。

主動脈瓣狹窄的盛行率不斷上升（主要發生在老年人口中），以及外科手術和經導管治療的良好臨床效果，推動了這個市場的發展。

隨著65歲及以上患者數量的不斷增加，外科主動脈瓣置換術（SAV​​R）和經導管主動脈瓣置換術（TAVR）的需求持續成長。由於TAVR具有微創、恢復時間短等優點，因此更受廣泛接受。根據西南醫學中心網站上的報導報道，美國每年約進行10萬例TAVR手術，截至2024年11月，該醫學中心已完成超過1000例經導管主動脈瓣置換術（TAVR）。

技術創新仍然是該市場的關鍵驅動力，其重點在於提高器械的耐用性並改善微創手術的輸送系統。製造商持續投資研發，以延長人工瓣膜的使用壽命，這對於可能更長時間佩戴人工瓣膜的年輕患者至關重要。

由於企業為獲取技術優勢或市場進入採取的策略性舉措，併購活動略有增加。 2024年7月，愛德華生命科學公司宣布一項約12億美元的策略投資，用於收購Jena Valve Technologies和Endotronics，以擴展其結構性心臟病產品組合。收購Jena Valve Technologies將鞏固愛德華在美國主動脈瓣膜置換器械行業的地位，並瞄準目前服務不足的瓣膜閉鎖不全領域。繼先前的投資後，收購Endotronics將使愛德華能夠憑藉其獲得FDA核准的Cordella感測器進軍心臟衰竭治療領域。這些策略性舉措旨在滿足患者未被滿足的需求，並支持公司的長期成長。

FDA要求進行廣泛的臨床試驗和上市後監測，這可能會延遲產品上市，但能確保高安全標準。 2025年5月，FDA核准了愛德華生命科學公司的Sapien 3 Ultra Resilia TAVR瓣膜，用於治療無症狀性主動脈瓣狹窄（AS）。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章美國主動脈瓣置換裝置市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場
    • 附隨市場
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 美國主動脈瓣置換裝置市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL分析
    • 法律規範

第4章美國主動脈瓣置換裝置市場：依產品分類的估算與趨勢分析

  • 細分儀表板
  • 美國主動脈瓣置換裝置市場：依產品分類的差異分析
  • 美國主動脈瓣置換裝置市場規模及產品趨勢分析（2021-2033）
  • 球囊擴張型
  • 自膨脹
  • 機械可膨脹
  • 主動脈瓣逆流

第5章美國主動脈瓣置換裝置市場：依瓣葉材料分類的估算與趨勢分析

  • 細分儀表板
  • 美國主動脈瓣置換裝置市場：依瓣葉材料分類的差異分析
  • 美國主動脈瓣置換裝置市場規模及趨勢分析（依瓣葉材料分類）（2021-2033 年）
  • 牛心包
  • 豬心包

第6章：美國主動脈瓣置換裝置市場：依框架材料分類的估算與趨勢分析

  • 細分儀表板
  • 美國主動脈瓣置換裝置市場：按框架材料分類的差異分析
  • 美國主動脈瓣置換裝置市場規模及趨勢分析（按框架材料分類）（2021-2033 年）
    • 鈷鉻
    • 鎳鈦合金
    • 其他

第7章美國主動脈瓣置換裝置市場：依最終用途分類的估算與趨勢分析

  • 細分儀表板
  • 美國主動脈瓣置換裝置市場：依最終用途分類的差異分析
  • 美國主動脈瓣置換裝置市場規模及趨勢分析（依最終用途分類）（2021-2033 年）
    • 住院設施
    • 門診設施

第8章 競爭情勢

  • 市場參與企業分類
  • 企業市場分析/堆圖分析
  • 公司簡介
    • Boston Scientific Corporation
    • Artivion, Inc
    • Edwards Lifesciences Corporation
    • LivaNova PLC
    • Medtronic
    • Abbott
Product Code: GVR-4-68040-755-9

U.S. Aortic Valve Replacement Devices Market Summary

The U.S. aortic valve replacement devices market size was estimated at USD 4.08 billion in 2024 and is projected to reach USD 9.35 billion by 2033, growing at a CAGR of 9.4% from 2025 to 2033. The market is primarily driven by the increasing prevalence of aortic stenosis in an aging population and favorable clinical outcomes from surgical and transcatheter approaches.

With a growing number of patients over age 65, demand for surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) continues to rise. Clinical outcomes have improved significantly over the past decade, with TAVR gaining wider acceptance due to its less invasive nature and reduced recovery times. As per the article on the Southwestern Medical Center website, approximately 100,000 TAVR procedures are performed annually in the U.S and as of November 2024, the medical centre had performed more than 1,000 transcatheter aortic valve replacement (TAVR) procedures.

Innovation remains a critical driving force within this market, with a strong focus on enhancing device durability and improving delivery systems for less invasive procedures. Manufacturers are continuously investing in research and development to extend the lifespan of prosthetic valves, which is crucial for younger patients who may live longer with their implanted devices.

Merger and acquisition is moderately high, driven by strategic efforts to gain technological advantages or market access. In July 2024, Edwards Lifesciences announced a strategic investment of around USD 1.2 billion to acquire JenaValve Technology and Endotronix, expanding its structural heart portfolio. Acquiring JenaValve Technology enhances Edward's position in the U.S. aortic valve replacement devices industry, targeting the underserved aortic regurgitation segment. The purchase of Endotronix, following an earlier investment, allows Edwards to enter heart failure management with its FDA-approved Cordella sensor. These strategic moves aim to address unmet patient needs and support long-term growth.

The FDA requires extensive clinical trials and post-market surveillance, which can delay product launches and ensure high safety standards. In May 2025, the FDA approved Edwards Lifesciences Sapien 3 Ultra Resilia TAVR valves for treating asymptomatic severe aortic stenosis (AS).

U.S. Aortic Valve Replacement Devices Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. aortic valve replacement devices market report based on product, leaflet material, frame material, and end use.

  • Product Outlook (Revenue, USD Billion, 2021 - 2033)
  • Balloon-expandable
  • Self-expandable
  • Mechanically expandable
  • Aortic regurgitation
  • Leaflet Material Outlook (Revenue, USD Billion, 2021 - 2033)
  • Bovine pericardium
  • Porcine pericardium
  • Frame Material Outlook (Revenue, USD Billion, 2021 - 2033)
  • Cobalt-chromium
  • Nitinol
  • Others
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Inpatient Facilities
  • Outpatient Facilities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Aortic Valve Replacement Devices Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. U.S. Aortic Valve Replacement Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
    • 3.3.3. Regulatory Framework

Chapter 4. U.S. Aortic Valve Replacement Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Aortic Valve Replacement Devices Market: Product Movement Analysis
  • 4.3. U.S. Aortic Valve Replacement Devices Market Size & Trend Analysis, by product, 2021 to 2033 (USD Billion)
  • 4.4. Balloon-expandable
    • 4.4.1. Balloon-expandable Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.5. Self-expandable
    • 4.5.1. Self-expandable Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.6. Mechanically expandable
    • 4.6.1. Mechanically expandable Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.7. Aortic regurgitation
    • 4.7.1. Aortic regurgitation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. U.S. Aortic Valve Replacement Devices Market: Leaflet Material Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Aortic Valve Replacement Devices Market: Leaflet Material Movement Analysis
  • 5.3. U.S. Aortic Valve Replacement Devices Market Size & Trend Analysis, by leaflet material, 2021 to 2033 (USD Billion)
  • 5.4. Bovine pericardium
    • 5.4.1. Bovine Pericardium Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.5. Porcine pericardium
    • 5.5.1. Porcine Pericardium Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. U.S. Aortic Valve Replacement Devices Market: By Frame Material Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Aortic Valve Replacement Devices Market: By Frame Material Movement Analysis
  • 6.3. U.S. Aortic Valve Replacement Devices Market Size & Trend Analysis, by frame material, 2021 to 2033 (USD Billion)
    • 6.3.1. Cobalt-chromium
      • 6.3.1.1. Cobalt-chromium Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 6.3.2. Nitinol
      • 6.3.2.1. Nitinol Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 6.3.3. Others
      • 6.3.3.1. Other Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. U.S. Aortic Valve Replacement Devices Market: By End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Aortic Valve Replacement Devices Market: By End Use Movement Analysis
  • 7.3. U.S. Aortic Valve Replacement Devices Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Billion)
    • 7.3.1. Inpatient Facilities
      • 7.3.1.1. Inpatient Facilities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.3.2. Outpatient Facilities
      • 7.3.2.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Position Analysis/ Heap Map Analysis
  • 8.3. Company Profiles
    • 8.3.1. Boston Scientific Corporation
      • 8.3.1.1. Participant's Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Artivion, Inc
      • 8.3.2.1. Participant's Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Edwards Lifesciences Corporation
      • 8.3.3.1. Participant's Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. LivaNova PLC
      • 8.3.4.1. Participant's Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Medtronic
      • 8.3.5.1. Participant's Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Abbott
      • 8.3.6.1. Participant's Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 U.S. Aortic Valve Replacement Devices Market, by Product, 2021 - 2033 (USD Billion)
  • Table 3 U.S. Aortic Valve Replacement Devices Market, by Leaflet Material, 2021 - 2033 (USD Billion)
  • Table 4 U.S. Aortic Valve Replacement Devices Market, by Frame Material, 2021 - 2033 (USD Billion)
  • Table 5 U.S. Aortic Valve Replacement Devices Market, by End Use, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. Aortic Valve Replacement Devices Market revenue, 2021 - 2033 (USD Billion)
  • Fig. 10 U.S. Aortic Valve Replacement Devices Market snapshot
  • Fig. 11 U.S. Aortic Valve Replacement Devices Market driver impact
  • Fig. 12 U.S. Aortic Valve Replacement Devices Market Restraint Impact
  • Fig. 13 Aortic Valve Replacement Devices product key takeaways (USD Billion)
  • Fig. 14 U.S. Aortic Valve Replacement Devices Market: product movement analysis
  • Fig. 15 Balloon-expandable Market, 2021 - 2033 (USD Billion)
  • Fig. 16 Self-expandable Market, 2021 - 2033 (USD Billion)
  • Fig. 17 Mechanically expandable Market, 2021 - 2033 (USD Billion)
  • Fig. 18 Aortic Regurgitation Market, 2021 - 2033 (USD Billion)
  • Fig. 19 Aortic Valve Replacement Devices Leaflet Material Key Takeaways (USD Billion)
  • Fig. 20 U.S. Aortic Valve Replacement Devices Market: Leaflet Material Movement Analysis
  • Fig. 21 Bovine Pericardium Market, 2021 - 2033 (USD Billion)
  • Fig. 22 Porcine Pericardium Market, 2021 - 2033 (USD Billion)
  • Fig. 23 U.S. Aortic Valve Replacement Devices Market Frame Material key takeaways (USD Billion)
  • Fig. 24 U.S. Aortic Valve Replacement Devices Market: Frame Material movement analysis
  • Fig. 25 Cobalt-Chromium Market, 2021 - 2033 (USD Billion)
  • Fig. 26 Nitinol Market, 2021 - 2033 (USD Billion)
  • Fig. 27 Others Market, 2021 - 2033 (USD Billion)
  • Fig. 28 U.S. Aortic Valve Replacement Devices Market by End Use Key Takeaways (USD Billion)
  • Fig. 29 U.S. Aortic Valve Replacement Devices Market: by End Use Movement Analysis
  • Fig. 30 Outpatient Facilities Market, 2021 - 2033 (USD Billion)
  • Fig. 31 Inpatient Facilities Market, 2021 - 2033 (USD Billion)
  • Fig. 32 Market Participant Categorization